West Branch Capital’s Abbott ABT Stock Holding History

West Branch Capital’s Portfolio ABT Stock Details ABT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$234K	Sell	2,576 -13,061	-84%	-$1.19M	0.05%	79
2026 Q1	$1.61M	Sell	15,637 -3,366	-18%	-$380K	0.43%	41
2025 Q4	$2.38M	Sell	19,003 -1,224	-6%	-$156K	0.61%	33
2025 Q3	$2.71M	Buy	20,227 +1,080	+6%	+$142K	0.71%	31
2025 Q2	$2.6M	Buy	19,147 +1,470	+8%	+$194K	0.77%	31
2025 Q1	$2.34M	Buy	17,677 +2,080	+13%	+$265K	0.78%	29
2024 Q4	$1.76M	Buy	15,597 +262	+2%	+$30.3K	0.56%	35
2024 Q3	$1.75M	Sell	15,335 -270	-2%	-$29.6K	0.6%	33
2024 Q2	$1.62M	Sell	15,605 -214	-1%	-$22.7K	0.6%	31
2024 Q1	$1.8M	Buy	15,819 +1,447	+10%	+$166K	0.73%	30
2023 Q4	$1.58M	Sell	14,372 -389	-3%	-$38.9K	0.74%	29
2023 Q3	$1.43M	Buy	14,761 +30	+0.2%	+$3.15K	0.75%	30
2023 Q2	$1.61M	Buy	14,731 +285	+2%	+$30.4K	0.8%	29
2023 Q1	$1.46M	Buy	14,446 +220	+2%	+$23.2K	0.82%	28
2022 Q4	$1.56M	Buy	14,226 +13	+0.1%	+$1.35K	0.96%	27
2022 Q3	$1.38M	Buy	14,213 +37	+0.3%	+$3.94K	0.85%	30
2022 Q2	$1.54M	Sell	14,176 -57	-0.4%	-$6.47K	0.89%	29
2022 Q1	$1.69M	Sell	14,233 -53	-0.4%	-$6.57K	0.81%	32
2021 Q4	$2.01M	Buy	14,286 +398	+3%	+$50.9K	0.86%	31
2021 Q3	$1.64M	Buy	13,888 +83	+0.6%	+$10.2K	0.79%	35
2021 Q2	$1.6M	Buy	13,805 +645	+5%	+$75.2K	0.79%	35
2021 Q1	$1.58M	Sell	13,160 -251	-2%	-$29.7K	0.92%	34
2020 Q4	$1.47M	Buy	13,411 +269	+2%	+$29.2K	0.87%	34
2020 Q3	$1.43M	Buy	13,142 +386	+3%	+$39.2K	0.91%	33
2020 Q2	$1.17M	Buy	12,756 +3,616	+40%	+$327K	0.82%	37
2020 Q1	$721K	Buy	9,140 +192	+2%	+$16K	0.69%	39
2019 Q4	$777K	Buy	8,948 +3,311	+59%	+$277K	0.54%	51
2019 Q3	$472K	Sell	5,637 -50	-0.9%	-$4.25K	0.35%	57
2019 Q2	$478K	Buy	5,687 +10	+0.2%	+$787	0.39%	59
2019 Q1	$454K	Buy	5,677 +11	+0.2%	+$818	0.41%	54
2018 Q4	$410K	Sell	5,666 -424	-7%	-$29.8K	0.43%	52
2018 Q3	$447K	Buy	6,090 +261	+4%	+$17.1K	0.33%	63
2018 Q2	$356K	Buy	+5,829	New	+$353K	0.28%	68

Other funds holding ABT

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Wellcome Trust London, United Kingdom $9.01B AUM 12.05% 1-Year Est. Return

Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return

Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

MMC

Mizuho Markets Cayman Grand Cayman, Cayman Islands $2.67B AUM 103.47% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

West Branch Capital's ABT Position: Q2 2026 in Review

West Branch Capital reduced its Abbott (ABT) stake by 84% in Q2 2026, selling an estimated $1.19M and leaving 2,576 shares worth $234K. The position accounts for 0.05% of the portfolio, ranked #79.

West Branch Capital first reported a position in ABT in Q2 2018 and has held it in 33 quarters since. The position peaked at $2.71M in Q3 2025. 940 funds tracked by Wall St. Rank hold ABT as of Q2 2026.

West Branch Capital held 2,576 shares of Abbott worth $234K as of Q2 2026.
West Branch Capital sold 13,061 Abbott shares in Q2 2026, an estimated $1.19M.
Abbott made up 0.05% of West Branch Capital's portfolio in Q2 2026, its #79 holding.
West Branch Capital first reported a position in Abbott in Q2 2018 and has held it in 33 quarters since.
West Branch Capital's Abbott position peaked at $2.71M in Q3 2025.
940 funds tracked by Wall St. Rank held Abbott as of Q2 2026.

Based on West Branch Capital's 13F filing for Q2 2026, filed 10 Jul 2026.